These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4551218)

  • 41. Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro.
    Rosenbaum JT; Hartiala KT; Webster RO; Howes EL; Goldstein IM
    Am J Pathol; 1983 Dec; 113(3):291-9. PubMed ID: 6228151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical demonstration of the activatable esterase of the rabbit netrophil involved in the chemotactic response.
    Ward PA; Becker EL
    J Immunol; 1970 Nov; 105(5):1057-67. PubMed ID: 5530772
    [No Abstract]   [Full Text] [Related]  

  • 43. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.
    Snyderman R; Phillips JK; Mergenhagen SE
    J Exp Med; 1971 Nov; 134(5):1131-43. PubMed ID: 5112201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fundamental study of osteoclast chemotaxis toward chemoattractants expressed in periodontitis.
    Niwa T; Mizukoshi K; Azuma Y; Kashimata M; Shibutani T
    J Periodontal Res; 2013 Dec; 48(6):773-80. PubMed ID: 23586648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.
    Mowat AG; Baum J
    J Clin Invest; 1971 Dec; 50(12):2541-9. PubMed ID: 5156708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.
    Ruddy S; Austen KF; Goetzl EJ
    J Clin Invest; 1975 Mar; 55(3):587-92. PubMed ID: 1167871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-glucan affects leukocyte navigation in a complex chemotactic gradient.
    Tsikitis VL; Albina JE; Reichner JS
    Surgery; 2004 Aug; 136(2):384-9. PubMed ID: 15300205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
    Perez HD; Goldstein IM; Webster RO; Henson PM
    J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation.
    Berliner S; Fishelson Z; Wasserman L; Pinkhas J; Aronson M
    Biomed Pharmacother; 1988; 42(1):69-72. PubMed ID: 3408808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells.
    Brier AM; Snyderman R; Mergenhagen SE; Notkins AL
    Science; 1970 Dec; 170(3962):1104-6. PubMed ID: 4319925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotactic activity from rabbit peritoneal neutrophils. Lack of identity with N-acetyl-DL-phenylalanine beta-napthyl esterase.
    Tsung PK; Showell HJ; Kegeles SW; Becker EL
    Biochim Biophys Acta; 1976 Aug; 445(1):112-7. PubMed ID: 986189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus.
    Perez HD; Goldstein IM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():53-8. PubMed ID: 3612652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of the Complement Alternative Pathway in Serum Chemotactic Activity During Sepsis.
    Xu G; Feng Y; Li D; Zhou Q; Chao W; Zou L
    Shock; 2018 Oct; 50(4):435-441. PubMed ID: 29040213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes.
    O'Flaherty JT; Kreutzer DL; Ward PA
    Am J Pathol; 1978 Mar; 90(3):537-50. PubMed ID: 564610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of radiographic contrast media on leukocyte locomotion.
    Carr DH; Walker AC; White RG
    Invest Radiol; 1981; 16(2):133-40. PubMed ID: 7216704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.